158 related articles for article (PubMed ID: 25589497)
1. A Combinatory Strategy for Detection of Live CTCs Using Microfiltration and a New Telomerase-Selective Adenovirus.
Ma Y; Hao S; Wang S; Zhao Y; Lim B; Lei M; Spector DJ; El-Deiry WS; Zheng SY; Zhu J
Mol Cancer Ther; 2015 Mar; 14(3):835-43. PubMed ID: 25589497
[TBL] [Abstract][Full Text] [Related]
2. A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients.
Kim SJ; Masago A; Tamaki Y; Akazawa K; Tsukamoto F; Sato J; Ozawa T; Tsujino Y; Noguchi S
Breast Cancer Res Treat; 2011 Aug; 128(3):765-73. PubMed ID: 21630023
[TBL] [Abstract][Full Text] [Related]
3. Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.
Kim E; Kim JH; Shin HY; Lee H; Yang JM; Kim J; Sohn JH; Kim H; Yun CO
Hum Gene Ther; 2003 Oct; 14(15):1415-28. PubMed ID: 14577922
[TBL] [Abstract][Full Text] [Related]
4. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
[TBL] [Abstract][Full Text] [Related]
5. Novel conditionally replicating adenovirus-mediated efficient detection of circulating tumor cells in lung cancer patients.
Ikemoto S; Sakurai F; Tokuoka S; Yamashita T; Takayama K; Hoshi K; Okabe T; Sumiyoshi I; Togo S; Takahashi K; Tachibana M; Mizuguchi H
PLoS One; 2023; 18(10):e0286323. PubMed ID: 37856461
[TBL] [Abstract][Full Text] [Related]
6. Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus.
Yabusaki M; Sato J; Kohyama A; Kojima T; Nobuoka D; Yoshikawa T; Sawada Y; Murakami K; Gohda K; Okegawa T; Nakamura M; Takamatsu K; Ito M; Kaneko K; Nakatsura T
Oncol Rep; 2014 Nov; 32(5):1772-8. PubMed ID: 25176113
[TBL] [Abstract][Full Text] [Related]
7. A novel approach for detecting viable and tissue-specific circulating tumor cells through an adenovirus-based reporter vector.
Wu P; Sokoll LJ; Kudrolli TA; Chowdhury WH; Ma R; Liu MM; Rodriguez R; Lupold SE
Prostate; 2014 Sep; 74(13):1286-1296. PubMed ID: 25065656
[TBL] [Abstract][Full Text] [Related]
8. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
Irving J; Wang Z; Powell S; O'Sullivan C; Mok M; Murphy B; Cardoza L; Lebkowski JS; Majumdar AS
Cancer Gene Ther; 2004 Mar; 11(3):174-85. PubMed ID: 14726958
[TBL] [Abstract][Full Text] [Related]
9. Telomerase-specific replication-selective virotherapy for human cancer.
Kawashima T; Kagawa S; Kobayashi N; Shirakiya Y; Umeoka T; Teraishi F; Taki M; Kyo S; Tanaka N; Fujiwara T
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):285-92. PubMed ID: 14734481
[TBL] [Abstract][Full Text] [Related]
10. High detection rate of circulating tumor cells in blood of patients with prostate cancer using telomerase activity.
Fizazi K; Morat L; Chauveinc L; Prapotnich D; De Crevoisier R; Escudier B; Cathelineau X; Rozet F; Vallancien G; Sabatier L; Soria JC
Ann Oncol; 2007 Mar; 18(3):518-21. PubMed ID: 17322541
[TBL] [Abstract][Full Text] [Related]
11. Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.
Bilsland AE; Merron A; Vassaux G; Keith WN
Cancer Res; 2007 Feb; 67(3):1299-307. PubMed ID: 17283167
[TBL] [Abstract][Full Text] [Related]
12. A novel approach for the detection and genetic analysis of live melanoma circulating tumor cells.
Xu MJ; Cooke M; Steinmetz D; Karakousis G; Saxena D; Bartlett E; Xu X; Hahn SM; Dorsey JF; Kao GD
PLoS One; 2015; 10(3):e0123376. PubMed ID: 25807549
[TBL] [Abstract][Full Text] [Related]
13. Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.
Uchino J; Takayama K; Harada A; Kawakami Y; Inoue H; Curiel DT; Nakanishi Y
Cancer Gene Ther; 2005 Sep; 12(9):737-48. PubMed ID: 15861179
[TBL] [Abstract][Full Text] [Related]
14. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
[TBL] [Abstract][Full Text] [Related]
15. Telomerase-specific oncolytic virotherapy for human cancer with the hTERT promoter.
Fujiwara T; Urata Y; Tanaka N
Curr Cancer Drug Targets; 2007 Mar; 7(2):191-201. PubMed ID: 17346111
[TBL] [Abstract][Full Text] [Related]
16. MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment.
Lapin M; Tjensvoll K; Oltedal S; Buhl T; Gilje B; Smaaland R; Nordgård O
Sci Rep; 2016 Jul; 6():28929. PubMed ID: 27432216
[TBL] [Abstract][Full Text] [Related]
17. Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance).
Magbanua MJM; Rugo HS; Wolf DM; Hauranieh L; Roy R; Pendyala P; Sosa EV; Scott JH; Lee JS; Pitcher B; Hyslop T; Barry WT; Isakoff SJ; Dickler M; Van't Veer L; Park JW
Clin Cancer Res; 2018 Mar; 24(6):1486-1499. PubMed ID: 29311117
[No Abstract] [Full Text] [Related]
18. Detection of circulating tumor cells in cervical cancer using a conditionally replicative adenovirus targeting telomerase-positive cells.
Takakura M; Matsumoto T; Nakamura M; Mizumoto Y; Myojyo S; Yamazaki R; Iwadare J; Bono Y; Orisaka S; Obata T; Iizuka T; Kagami K; Nakayama K; Hayakawa H; Sakurai F; Mizuguchi H; Urata Y; Fujiwara T; Kyo S; Sasagawa T; Fujiwara H
Cancer Sci; 2018 Jan; 109(1):231-240. PubMed ID: 29151279
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study.
Ito H; Inoue H; Sando N; Kimura S; Gohda K; Sato J; Murakami K; Ito S; Odaka N; Satodate H; Kudo SE
BMC Cancer; 2012 Aug; 12():346. PubMed ID: 22873704
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line.
Song JS; Kim HP; Yoon WS; Lee KW; Kim MH; Kim KT; Kim HS; Kim YT
Biosci Biotechnol Biochem; 2003 Nov; 67(11):2344-50. PubMed ID: 14646192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
